SCHEMBL6570414

SCHEMBL6570414

OC(CCCc1ccncc1)CCCc1ccncc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.50
LOXL2 Q9Y4K0 2/20 0.46
MMP12 P39900 1/20 0.45
MMP13 P45452 1/20 0.45
HRH3 Q9Y5N1 2/20 0.43
HRH4 Q9H3N8 1/20 0.43
CYP1A2 P05177 4/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2C9 P11712 4/20 0.42
CYP2C19 P33261 4/20 0.42
NAAA Q02083 1/20 0.42
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP2D6 P10635 3/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TRPA1 O75762 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8466469 0.91 LMNA (0.46) HRH1LOXL2MMP12MMP13HRH3
SCHEMBL10399076 0.83 HRH1 (0.47) HRH1LOXL2MMP12MMP13HRH3
SCHEMBL10399075 0.83 HRH1 (0.47) HRH1LOXL2MMP12MMP13HRH3
SCHEMBL14273406 0.81 HRH1 (0.53) HRH1LOXL2MMP12MMP13HRH3
SCHEMBL743000 0.79 HRH1 (0.47) HRH1LOXL2MMP12MMP13HRH3
SCHEMBL3169642 0.78 HRH1 (0.50) HRH1LOXL2HRH3HRH4CYP1A2
SCHEMBL726645 0.78 HRH1 (0.73) HRH1LOXL2HRH3HRH4CYP1A2
SCHEMBL351920 0.78 HRH1 (0.65) HRH1LOXL2HRH3HRH4CYP1A2
SCHEMBL9079346 0.77 LTB4R (0.46) HRH1MMP12MMP13CYP3A4ALDH1A1
SCHEMBL5833581 0.77 TRPA1 (0.56) TDP1TRPA1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1420009-A2 Novel amino acid derivatives with improved multi-drug resistance activity Vertex Pharmaceuticals Incorporated (US) 2004-05-19 EP disclosed
EP-0797567-B1 NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMA (US) 2004-02-11 EP disclosed
EP-0946190-B1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE OUTGROWTH VERTEX PHARMA (US) 2003-09-24 EP disclosed
US-6284778-B1 NEUROTROPHIC AGENT VERTEX PHARMACEUTICALS INCORPORATED 2001-09-04 US disclosed
US-6172086-B1 TREATING PARKINSON*S DISEASE, ALZHIEMER*S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS AND OTHER NERVOUS SYSTEM DISORDERS VERTEX PHARMACEUTICALS INCORPORATED 2001-01-09 US disclosed
US-5840736-A PEPTIDES FOR NERVE GROWTH VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-11-24 US disclosed
EP-0797567-A1 NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY Vertex Pharmaceuticals Incorporated (US) 1997-10-01 EP disclosed
US-5543423-A USED IN MULTI-DRUG RESISTANCE CANCER THERAPY VERTEX PHARMACEUTICALS, INCORPORATED (US) 1996-08-06 US disclosed
WO-1996015101-A1 NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMACEUTICALS INCORPORATED (US) 1996-05-23 WO disclosed